Skip to main content

and
  1. Article

    Open Access

    A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes

    Studies of dipeptidyl peptidase (DPP)-4 inhibitors report heterogeneous effects on endothelial function in patients with type 2 diabetes (T2D). This study assessed the effects of the DPP-4 inhibitor linaglipti...

    Thomas Jax, Alin Stirban, Arne Terjung, Habib Esmaeili in Cardiovascular Diabetology (2017)